Different from extracellular soluble antigens, the antigens on extracellular nanoparticles often undergo a cross-presentation process after being ingested by APCs, and are loaded on MHC I and presented to CD8+ T cells, the main force to kill tumor cells [12, 13]. This evidence concerns the gene CD8A and neoplasm.